Trials / Completed
CompletedNCT00309036
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Cocktail of Recombinant Derivatives of Major Allergens of Timothy Grass (Phleum Pratense).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Allergopharma GmbH & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The trial is performed to assess efficacy and safety of a recombinant grass Pollen allergen cocktail in allergic rhinoconjunctivitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Recombinant grass pollen |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2006-09-01
- Completion
- 2008-05-01
- First posted
- 2006-03-31
- Last updated
- 2013-03-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00309036. Inclusion in this directory is not an endorsement.